Breaking News

  • 7 hours ago

  • Vaibhavi M.

FDA Approves GSK’s Lynavoy As First US Therapy For Cholestatic Pruritus In Primary Biliary Cholangitis
Breaking News

More News

Rhythm Pharma’s IMCIVREE® Secures FDA Approval For Acquired Hypothalamic Obesity After Strong Phase III BMI Reduction Data

Rhythm Pharma’s IMCIVREE® Secures FDA Approval For Acquired Hypothalam...

Vaibhavi M.

FDA Approves Novo Nordisk’s Wegovy® HD For Long-Term Weight Management, Delivers Up To 20.7% Weight Loss; US Launch Planned For April 2026

FDA Approves Novo Nordisk’s Wegovy® HD For Long-Term Weight Management...

Vaibhavi M.

Pfizer’s TALZENNA–XTANDI Combo Shows Strong Phase III Results In HRR-Mutated Metastatic Prostate Cancer, With Significant Progression-Free Survival Benefit

Pfizer’s TALZENNA–XTANDI Combo Shows Strong Phase III Results In HRR-M...

Vaibhavi M.

CellCarta And Biofidelity Expand Global Alliance With Exclusive Aspyre® Lung Deployment, New Strategic Deal Streamlines Lung Cancer Trials And Targeted Genomic Testing

CellCarta And Biofidelity Expand Global Alliance With Exclusive Aspyre...

Vaibhavi M.

Ad
Advertisement
Ad
Advertisement
Ad
Advertisement